Dexcom Inc (DXCM)

Dexcom Inc Stock (DXCM) Financials Data

*All numbers in millions

Period End Date	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	2.76%1,344.50	1,308.40	1,191.90	1,259.60	1,209.30
Cost Of Revenue	0.36%480.10	478.40	441.60	466.90	477.90
Gross Profit	4.14%864.40	830.00	750.30	792.70	731.40
	4.98%537.20	511.70	495.00	469.70	488.90
Selling, General, and Administrative	4.71%375.60	358.70	349.70	321.50	331.40
Research and Development	5.62%161.60	153.00	145.30	148.20	157.50
Operating Income/Loss	2.80%327.20	318.30	255.30	323.00	242.50
Income/Loss From Continuing Operations Before Tax	5.42%334.70	317.50	269.50	340.70	352.30
Income Tax Expense/Benefit, Deferred	200.00%-0.90	-0.30	0.30	78.90	118.00
Income Tax Expense/Benefit	12.87%59.60	68.40	70.00	73.40	68.50
	10.44%275.10	249.10	199.50	267.30	283.80
Attributable To Parent	10.44%275.10	249.10	199.50	267.30	283.80
Basic Average Shares	1.96%374.70	382.20	385.10	-1.20	391.10
Diluted Average Shares	1.69%383.50	390.10	393.60	-2.20	407.40
Basic Earnings Per Share	12.31%0.73	0.65	0.52	0.69	0.73
Diluted Earnings Per Share	12.50%0.72	0.64	0.51	0.67	0.70